Stock Scorecard



Stock Summary for Neogen Corp (NEOG) - $10.22 as of 2/2/2026 8:40:35 AM EST

Total Score

5 out of 30

Safety Score

24 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for NEOG

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for NEOG

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for NEOG

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for NEOG

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for NEOG (24 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 6
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 4
Book Value to Price (Max of 10) 2
Analyst Buy Ratings (Max of 5) 2
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 10
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for NEOG

Zacks Research Forecasts Neogen's Q3 Earnings (NASDAQ:NEOG) 2/2/2026 6:43:00 AM
Neogen Corporation (NASDAQ:NEOG) Given Average Recommendation of "Hold" by Brokerages 2/1/2026 10:02:00 AM
Microbial contamination prompts Neogen recall of pet wound solution 1/29/2026 11:30:00 PM
Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination 1/29/2026 5:36:00 PM
Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution 1/28/2026 6:27:00 PM
Mizuho Markets Americas LLC Takes $11.42 Million Position in Neogen Corporation $NEOG 1/19/2026 12:57:00 PM
Neogen (NEOG) Q2 2026 Earnings Call Transcript 1/16/2026 10:27:00 PM
Neogen CEO Nassif Mikheal buys $1278 in shares 1/16/2026 3:29:00 PM
Neogen (NEOG) Is Up 26.5% After Raising 2026 Outlook And Trimming Losses - Has The Bull Case Changed? 1/13/2026 9:28:00 PM
Neogen announces 2 senior leadership appointments 1/10/2026 10:27:00 PM

Financial Details for NEOG

Company Overview

Ticker NEOG
Company Name Neogen Corp
Country N/A
Description Neogen Corporation (NEOG), headquartered in Lansing, Michigan, is a leading provider of innovative solutions focused on food safety, animal health, and biosecurity, catering to the essential needs of the agricultural and food production sectors. The company boasts a diverse portfolio of advanced diagnostic tests, cleaning and sanitation products, and nutritional supplements, all designed to uphold and enhance industry standards. With a commitment to innovation and strategic market expansion, Neogen is well-positioned as a crucial partner for organizations prioritizing quality and safety in their operations. Its dedicated emphasis on improving global food safety and animal health not only reflects its mission but also highlights its growth potential in an evolving agricultural landscape.
Sector Name HEALTHCARE
Industry Name DIAGNOSTICS & RESEARCH
Most Recent Quarter 11/30/2025
Next Earnings Date 4/1/2026

Stock Price History

Last Day Price 10.22
Price 4 Years Ago 15.23
Last Day Price Updated 2/2/2026 8:40:35 AM EST
Last Day Volume 3,300,420
Average Daily Volume 3,904,462
52-Week High 11.96
52-Week Low 3.87
Last Price to 52 Week Low 164.08%

Valuation Measures

Trailing PE N/A
Industry PE 37.63
Sector PE 188.49
5-Year Average PE 59.83
Free Cash Flow Ratio 15.25
Industry Free Cash Flow Ratio 97.66
Sector Free Cash Flow Ratio 30.14
Current Ratio Most Recent Quarter 3.91
Total Cash Per Share 0.67
Book Value Per Share Most Recent Quarter 9.68
Price to Book Ratio 1.03
Industry Price to Book Ratio 452.77
Sector Price to Book Ratio 57.14
Price to Sales Ratio Twelve Trailing Months 2.45
Industry Price to Sales Ratio Twelve Trailing Months 5.45
Sector Price to Sales Ratio Twelve Trailing Months 20.56
Analyst Buy Ratings 1
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 217,526,000
Market Capitalization 2,223,115,720
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.19%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -85.60%
Annual Earnings Growth -11,491.59%
Reported EPS 12 Trailing Months -2.78
Reported EPS Past Year 0.14
Reported EPS Prior Year 0.33
Net Income Twelve Trailing Months -602,739,000
Net Income Past Year -1,092,044,000
Net Income Prior Year -9,421,000
Quarterly Revenue Growth YOY -2.80%
5-Year Revenue Growth 16.43%
Operating Margin Twelve Trailing Months -2.39%

Balance Sheet

Total Cash Most Recent Quarter 145,340,000
Total Cash Past Year 129,004,000
Total Cash Prior Year 170,611,000
Net Cash Position Most Recent Quarter -647,586,000
Net Cash Position Past Year -745,806,000
Long Term Debt Past Year 874,810,000
Long Term Debt Prior Year 888,391,000
Total Debt Most Recent Quarter 792,926,000
Equity to Debt Ratio Past Year 0.70
Equity to Debt Ratio Most Recent Quarter 0.73
Total Stockholder Equity Past Year 2,071,254,000
Total Stockholder Equity Prior Year 3,144,142,000
Total Stockholder Equity Most Recent Quarter 2,104,488,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -30,807,000
Free Cash Flow Per Share Twelve Trailing Months -0.14
Free Cash Flow Past Year -46,351,000
Free Cash Flow Prior Year -76,157,000

Options

Put/Call Ratio 0.02
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.79
MACD Signal 0.74
20-Day Bollinger Lower Band 4.04
20-Day Bollinger Middle Band 6.96
20-Day Bollinger Upper Band 9.88
Beta 1.95
RSI 72.31
50-Day SMA 6.56
150-Day SMA 0.00
200-Day SMA 14.98

System

Modified 1/31/2026 4:10:12 AM EST